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Lipid II is essential for nisin-mediated pore formation at nano-molar concentrations. We tested whether nisin resistance could
result from diﬀerent Lipid II levels, by comparing the maximal Lipid II pool in Micrococcus ﬂavus (sensitive) and Listeria monocy-
togenes (relatively insensitive) and their nisin-resistant variants, with a newly developed method. No correlation was observed
between the maximal Lipid II pool and nisin sensitivity, as was further corroborated by using spheroplasts of nisin-resistant and
wild-type strains of M. ﬂavus, which were equally sensitive to nisin.
 2004 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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The development of resistance of bacteria towards
antibiotics is a global problem that calls for new ap-
proaches to kill harmful microorganisms. A promising
alternative for antibiotics is nisin, an antimicrobial pep-
tide that displays a broad spectrum of activity against
Gram-positive bacteria and is produced by Lactococcus
lactis [1]. The peptide is already widely used in the food
industry as a safe and natural preservative [2]. Nisin kills
bacteria primarily by formation of pores in the cytoplas-
mic membrane via binding to Lipid II [3,4].0378-1097/$22.00  2004 Federation of European Microbiological Societies
doi:10.1016/j.femsle.2004.08.033
* Corresponding author. Tel.: +31 50 3632408; fax: +31 50 3632348.
E-mail address: n.e.kramer@biol.rug.nl (N.E. Kramer).Lipid II plays a central role in bacterial cell wall bio-
synthesis: it contains bactoprenyl-phosphate, which car-
ries the cell wall building blocks UDP-GlcNAc (uridine
5 0-diphospho-N-acetylglucosamine) and UDP-Mur-
NAc-pp (uridine 5 0-diphospho-N-acetylmuramoyl-pen-
tapeptide) across the cytoplasmic membrane (Fig. 1).
As a consequence of this crucial function during bacte-
rial growth, Lipid II, and, indirectly, the bactoprenyl-
phosphate pool, have become important targets for
antibiotics.
Despite its prolonged use as a preservative in the food
industry, no reports of emerging resistance towards nisin
have yet appeared. This could be related to the double
mode of action of nisin. By binding to Lipid II, it inhib-
its cell wall synthesis while on the other hand it
forms pores in the cytoplasmic membrane. However,. Published by Elsevier B.V. All rights reserved.
Table 1
Bacterial strains and plasmids used in this study
Strains or plasmid Source
Micrococcus ﬂavus NIZO B423 NIZOa Food Research
Micrococcus ﬂavus NIZO B423 NisR This work
Listeria monocytogenes NIZO B1242 NIZOa Food Research
Listeria monocytogenes NIZO B1242 NisR This work
Escherichia coli BL21 DE3 NCCBb
plysS; PET 21b+ murG S. Walker, Princeton
a Dutch Institute of Dairy Research.
b The Netherlands Culture Collection of Bacteria.
Fig. 1. Peptidoglycan synthesis: The transfer of the phospho-MurNAc-
pentapeptide moiety of UDP-MurNAc-pentapeptide to the membrane
acceptor bactoprenyl-phosphate is catalyzed by the transferase MraY
and leads to synthesis of Lipid I. Addition of GlcNAc to Lipid I, by
the transferase MurG, results in Lipid II, which carries the complete
disaccharide peptide monomer unit: GlcNAc-MurNAc-L-Ala-c-D-
Glu-A2pm (diaminopimelic acid) (or L-Lys)-D-Ala-D-Ala. Finally,
the molecule is translocated across the membrane by an unknown
transport mechanism and GlcNAc-MurNAc-pentapeptide is released
and integrated into peptidoglycan [26].
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tory settings [5–8]. The possible role of Lipid II in resist-
ance development is still unknown.
The natural variation in the sensitivity of Gram-pos-
itive bacteria towards nisin is considerable. Even be-
tween closely related species, minimal inhibitory
concentrations (MIC) range from 5 lg/L to 5 mg/L
[9]. Insights into how bacteria develop nisin resistance
and the basis of the diﬀerences in nisin sensitivity are
of major importance for future applications of nisin or
nisin variants. Here, we investigate the possible role of
Lipid II in determining the diﬀerence in sensitivity of
bacteria to nisin. Two diﬀerent species of Gram-positive
bacteria, namely M. ﬂavus and L. monocytogenes, and
their isogenic nisin-resistant variants were selected.
The four strains cover a broad range of natural varia-
tion in nisin sensitivity, varying from 20 lg/L to 10
mg/L. Using a newly developed assay for the quantiﬁca-
tion of the maximal amount of Lipid II in bacteria, we
examined whether variations in the amount of Lipid II
are responsible for the diﬀerences in nisin sensitivity.2. Materials and methods
2.1. Chemicals and materials
All chemicals were of analytical grade. UDP-GlcNAc
was from Sigma–Aldrich Chemie (Steinheim, Germany),
[14C]-UDP-GlcNAc from NEN Life Sciences, Inc. (Bos-
ton, MA, USA).2.2. Bacterial strains, cloning and culture conditions
Bacterial strains and plasmids used in this study are
listed in Table 1. M. ﬂavus was grown at 30 C with
shaking at 200 rpm, in Trypton Soy Broth (Oxoid, Bas-
ingstoke, Hampshire, UK). L. monocytogenes was
grown at 37 C in Brain Heart Infusion (Oxoid). Escher-
ichia coli was grown in TY broth at 37 C while shaking
at 200 rpm. E. coli BL21 (DE3) (plysS; pET21b+), was
used for production and isolation of MurG, carrying a
N-terminal His6-tag. Media contained ampicillin at 100
mg/L or chloramphenicol at 25 mg/L, when appropriate
[10].2.3. Generation of nisin-resistant strains
A nisin stock solution was derived from nisaplin,
(2.5% nisin, Aplin and Barrett, Danisco, Copenhagen,
Denmark), as described earlier [11], and was used to
obtain nisin-resistant isogenic variants of M. ﬂavus
and L. monocytogenes via the following procedure;
the strains were grown in broth with 10 lg/L nisin
for M. ﬂavus and 900 lg/L nisin for L. monocytogenes,
which is just below the respective MIC values. Subse-
quently, the strains were repeatedly inoculated in media
with increasing concentrations of nisin. After every
20th generation, nisin-resistant cultures were plated
on nisin-containing plates and single colonies were
picked for further enrichment. Nisin-resistant single
colonies were picked, and grown in the presence of the
appropriate nisin concentration and stored at 80 C.
Nisin was always added to the growth media to main-
tain resistance.2.4. Antimicrobial activity determinations
M. ﬂavus and L. monocytogenes were grown over-
night. The NisR variants were grown in the presence
of nisin (2.5 mg/L for M. ﬂavus NisR and 10 mg/L for
L. monocytogenes NisR). Hereafter the MIC values were
essentially obtained as described before [12].
Table 2
Minimal inhibitory concentration for nisin and bactoprenyl-phosphate
content in the cytoplasmic membrane of L. monocytogenes and M.
ﬂavus strains
Strain MIC (lg/L) 11-p/Pia,b 11-p/cell (·105)
M. ﬂavus 20 1:190 ± 85 1.9
M. ﬂavus NisR 2500 1:172 ± 41 1.8
L. monocytogenes 1000 1:108 ± 22 2.4
L. monocytogenes NisR 10,000 1:119 ± 28 2.2
a 11-p = Bactoprenyl-phosphate and Pi = phospholipids.
b Average of ﬁve independent experiments.
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II max.) in bacterial membranes
Bacterial cells were grown until mid-exponential
growth phase (OD600 of 0.5–0.8). Membranes were
isolated from lysozyme-treated cells by centrifugation at
40,000g for 45 min. They were washed twice in 50 mM
Tris–HCl, 10 mM MgCl2, pH 7.5 or 100 mM potassium
phosphate, pH 7.5, for M. ﬂavus and L. monocytogenes,
respectively, and stored in liquid nitrogen. Membranes
were thawed and incubated in the presence of suﬃcient
precursor sugars and Triton X-100 to ensure total con-
version of endogenous Lipid I, undecaprenyl di-phos-
phate (11-pp), and, undecaprenyl mono-phosphate (11-
p pools) to Lipid II. In short: membranes (2 mM of
Lipid-phosphate (Pi)) were gently mixed with a solu-
tion containing Tris–HCl (pH 8, 100 mM), MgCl2
(6 mM), UDP-MurNAc-pentapeptide (45 lM), [14C]-
UDP-GlcNAc (45 lM) with a speciﬁc activity of 0.45
GBq/mmol, 1% TX-100 and an excess of H6-MurG
(for L. monocytogenes) and incubated at RT for 1 h.
H6-MurG was isolated from E. coli BL21 (DE3) (plysS,
pET21b+ murG) as described previously [10]. Subse-
quently, 7.5 ll of this mixture was spotted on cellulose
membranes (Merck), which were developed in isobutyric
acid: ammonia (7:2). The radioactive spots were visual-
ized and quantiﬁed using a phosphor-imager (Molecular
Dynamics, Sunnyvale, CA) and the Image Quant 1.2
program (Molecular Dynamics). The number of cells
in 1 ll of culture was determined using light microscopy.
The amount of phospholipids per ll of culture was
determined by extracting them according to Bligh and
Dyer [13]. The amount of organic phosphate in the
sample was determined according to Rouser [14]. This
allowed to determine the amount of Lipid IImax per
cell, expressed as the ratio between Lipid IImax and
phospholipids.
2.6. Membrane potential measurements on whole cells and
spheroplasts
Cells of 10 ml overnight culture of M. ﬂavus were
washed in 3 ml of 10 mM potassium phosphate buﬀer
(pH 7.5), 5 mM MgSO4 and resuspended in 3 ml of
the same buﬀer. A parallel sample was resuspended in
a solution containing 1 M sucrose, 100 mM NaCl and
lysozyme (1 lg/ml) and incubated at 30 C for 30 min
to obtain spheroplasts. Cells or spheroplasts were di-
luted to an OD600 of 0.075 in the same buﬀer containing
a ﬁnal concentration of 2 lM 3,3-dipropylthiacarbocya-
nine iodide (DiSC3(5)) (Molecular Probes, Leiden, the
Netherlands). The membrane potential (Dw) was moni-
tored with the DiSC3(5) probe (excitation wavelength,
651 nm; emission wavelength, 675 nm) using a Perkin–
Elmer model 650-10S ﬂuorescence spectrophotometer
(Perkin–Elmer Corp., Oosterhout, the Netherlands), at25 C. At maximal dye incorporation, puriﬁed nisin
was added (concentrations ranging from 10 nM to 1.8
lM) to the suspension. To set the arbitrary level at
100% dissipation, valinomycin (1 lM end concentra-
tion) was added to the suspension to completely dissi-
pate the membrane potential. The ethanol level in the
suspension never exceeded 0.5%.3. Results and discussion
3.1. Isolation of NisR variants of M. ﬂavus and
L. monocytogenes
Nisin-resistant variants were obtained as described in
Section 2. A NisR variant of L. monocytogenes was ob-
tained that could grow in the presence of 10 mg/L, which
is 10 times the MIC value of the L. monocytogenes-par-
ent strain. Interestingly, an identical ﬁnal MIC value
was found earlier with diﬀerent Listeria strains [15], sug-
gesting that about 10 mg/L is the limit to which these
bacteria can become resistant. A nisin-resistant M. ﬂa-
vus strain could grow in the presence of 2.5 mg/L, which
is 125 times the MIC value of the wild-type strain (Table
2). The MICs for both parent strains are within the con-
centration range where nisin activity in model systems is
dependent on the presence of Lipid II [16], implying that
the diﬀerences in sensitivity could be due to diﬀerences
in Lipid II content. The MIC value of L. monocytogenes
NisR is in the concentration range where nisin can be ac-
tive independent of Lipid II, but still depends on the
presence of anionic phospholipids [16,17]. In this case
the acquired nisin-resistance, could result in part from
Lipid II independent mechanisms.
3.2. The maximal Lipid II pool in the cytoplasmic
membrane is not correlated to nisin sensitivity
To test whether the Lipid II content in the bacterial
membrane contributed to the diﬀerence in sensitivity of
bacteria to nisin, we determined the maximal Lipid II
content in the diﬀerent strains described above. However,
it is diﬃcult to determine the Lipid II content directly, be-
cause of the very short half-life of Lipid II in the living cell
[18], resulting in hardly detectable endogenous Lipid II in
Table 3
3,3-Dipropylthiacarbocyanine iodide (DisC3(5)) release from whole
cells and protoplasts of sensitive and resistant strains ofM. ﬂavus after
exposure to nisin
M. ﬂavusa (%) M. ﬂavus NisRa (%)
Whole cells
1 nM nisin ne ne
10 nM nisin 17 ± 6 ne
100 nM nisin 31 ± 10 12 ± 1
500 nM nisin 58 ± 2 14 ± 2
1.8 lM nisin nd 38 ± 5
Protoplasts
10 nM nisin 58 ± 8 38 ± 5
100 nM nisin 100 70 ± 3
ne = No detectable eﬀect.
nd = Not done.
a Mean of three independent experiments.
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pools of Lipids I and II has been described for E. coli
[19]. Unfortunately, this method is not generally applica-
ble to other bacteria as it makes use of an E. coli strain
with a speciﬁc mutation in the diaminopimelic acid bio-
synthesis route. As an alternative, we devised a method
to determine the maximal amount of Lipid II that the
bacterial membrane could contain, by complete conver-
sion of the 11-p, 11-pp and Lipid I pools into Lipid II.
[14C]-UDP-GlcNAc was used to quantify Lipid II as de-
scribed in Section 2. Although this method does not di-
rectly measure the pool level of Lipid II, it is capable of
revealing (up or down)-regulation in bactoprenyl-phos-
phate biosynthesis. Levels of bactoprenyl-pyrophosphate
and Lipid I are presumably very low as compared to the
bactoprenyl-phosphate levels [20], and therefore we as-
sume that the amount of Lipid II in our assay is propor-
tional to the bactoprenyl-phosphate pool of the bacteria.
This assumption seems justiﬁed when the thick peptidog-
lycan layer of Gram-positive bacteria is considered: pept-
idoglycan synthesis is most likely the main pathway that
uses the bactoprenyl-phosphate pool.
With this method, the ratios of Lipid IImax to phosp-
holipids in the four strains used in this study were esti-
mated to range from 1:190 to 1:108 (Table 2). Thus,
between two bacterial strains with a 50-fold diﬀerence
in MIC value only a 2-fold diﬀerence in maximal Lipid
II content could be detected, which cannot be responsi-
ble for the large diﬀerences in MIC values. Storm and
Strominger [21] also determined the total pool level of
bactoprenyl-phosphate, by determining the number of
bound bacitracin molecules per bacterium at saturation,
concluding that the total pool level of bactoprenyl-phos-
phate in M. lysodeikticus was 2 · 105 molecules per cell,
which is very similar to our result.
The maximal amount of Lipid II in the membranes of
the NisR variants ofM. ﬂavus and L. monocytogenes and
the two parental strains did not show a signiﬁcant diﬀer-
ence (Table 2). Because the availability of bactoprenyl-
phosphate is rate-limiting for several aspects of cell wall
synthesis in Staphylococcus aureus [22] and Bacillus sp.
[23], we conclude that nisin resistance of our NisR
strains is not caused by down-regulation of the bacto-
prenyl-phosphate content, which would result in lower
Lipid II pool levels in the cells. Thus, the nisin resistance
of the NisR strains is not directly related to the mem-
brane Lipid II levels. The results do emphasize the
importance of a stable Lipid II cycle in bacterial cell wall
synthesis, probably because this molecule is indispensa-
ble for cell wall biosynthesis.
3.3. Removal of the cell wall dramatically changes the
sensitivity to nisin
The above conclusion implies that spheroplasts of the
nisin-sensitive and -resistant strains would be equallysensitive to nisin. Interestingly, when the sensitivity of
the spheroplasts was compared to the sensitivity of the
intact parental cells, it became apparent that removal
of the cell wall dramatically changed the sensivity of
bothM. ﬂavus strains (Table 3). Dissipation of the mem-
brane potential was already observed after addition of
10 nM of nisin to the spheroplasts of both sensitive
and resistant strains (Table 3). This suggests that the cell
wall is an important factor in acquiring nisin resistance,
as has been proposed before [15,24,25]. Strikingly, only
a slight (1.4-fold) diﬀerence in dissipation remained be-
tween the spheroplasts of wild-type and the NisR vari-
ant. The 1.4-fold diﬀerence in sensitivity that remains
could be due to a decrease in negatively charged phosp-
holipids composition observed in the nisin-resistant
strains (data not shown). These ﬁndings support our
earlier suggestion that Lipid II levels are kept constant.
In conclusion, our results indicate that, despite the
essential role of Lipid II in the mode of action of nisin,
there is no direct role of Lipid II in nisin-resistance. The
observed resistance must originate from other mecha-
nisms. The results of the spheroplast experiments suggest
that the cell wall has been changed such that nisin is una-
ble to gain access to Lipid II, and hence that the cell wall is
the major determinant in acquiring nisin resistance.Acknowledgements
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